MedTrace Logo

Duloxetine for Postoperative Analgesia After Modified Radical Mastectomy

NCT05442268 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2022-07-20

No results posted yet for this study

Summary

The aim of this study is to evaluate the role of duloxetine in controlling pain after radical mastectomy.

Conditions

  • Modified Radical Mastectomy
  • Postoperative Analgesia

Interventions

PROCEDURE

Acetaminophen group

patients will receive intravenous 500 mg acetaminophen(every 6 hours postoperatively

PROCEDURE

Duloxetine group

Patients will receive duloxetine 30 mg every 12 hours for 3 days before surgery, 30 mg 2 hours preoperatively and 30 mg 12 hours postoperatively and intravenous 500 mg acetaminophen every 6 hours postoperatively

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-16
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05442268 on ClinicalTrials.gov